References
1- Lecube A., Azcona C., Azriel S., et al. “2ª edición Guía Española GIRO: guía española del manejo integral y multidisciplinar de la obesidad en personas adultas, 2024 https://www.seedo.es/index.php/guia-giro.
2-Kyle TK, Dhurandhar EJ, Allison, DB. Regarding Obesity as a Disease: Evolving Policies and Their implications. Endocrinol Metab Clin North Am 2016; 45: 511-520. doi: 10.1016/j.ecl.2016.04.004.
3- Townsend N, Vogel C, Allender S, et al. WHO European Regional Obesity: Report 2022. Copenhagen: WHO Regional Office for Europe; 2022 Licence CC BY-NC-SA 3.0 IGO [Internet]. [cited 2025 Jan 06]. Available from: https://iris.who.int/bitstream/handle/10665/353747/9789289057738-eng.pdf
4- Preiss Contreras Y, Ramos Salas X, Ávila Oliver C, et al. Obesidad en adultos: guía de práctica clínica adaptada para Chile. Medwave. 2022 Nov;22(10):2649. https://www.medwave.cl/revisiones/consenso/2649.html
5- Wharton S, Lau DCW, Vallis M, et al. Obesity in adults: A clinical practice guideline. CMAJ. 2020 Aug 4;192(31):E875–91.
6- Breen C, O’Connell J, Geoghegan J, et al. Obesity in Adults: A 2022 Adapted Clinical Practice Guideline for Ireland. Obes Facts. 2022 Oct 24;15(6):736–52. doi: 10.1159/000527131.
7- Aranceta-Bartrina J, Serra-Majem L, Foz-Saka M et al.; grupo colaborativo SEEDO. Prevalencia de la obesidad en España. Med Clin (Barc) 2005; 125:460-6.
8- World Obesity Federation. World Obesity Atlas 2024. London: World Obesity Federation, 2024. https://data.worldobesity.org/publications/?cat=22
9- Hassapidou M, Vlassopoulos A, Kalliostra M, et al. European Association for the Study of Obesity Position Statement on Medical Nutrition Therapy for the Management of Overweight and Obesity in Adults Developed in Collaboration with the European Federation of the Associations of Dietitians. Obes Facts. 2023;16(1):11–28. Available from: https://www.karger.com/Article/FullText/528083
10- Pantalone KM, Hobbs TM, Chagin KM et al. 2017.Prevalence and recognition of obesity and its associated comorbidities: cross-sectional analysis of electronic health record data from a large US integrated health system. BMJ Open 7(11):e017583
11- Marjot T, Moolla A, Cobbold JF, et al. Nonalcoholic Fatty Liver Disease in Adults: Current Concepts in Etiology, Outcomes, and Management. Endocr Rev. 2020 Feb 1;41(1):66–117.
12- Cuadrado A, Orive A, García-Suárez C, et al. Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma. Obes Surg. 2005 Mar;15(3):442-6. doi: 10.1381/0960892053576596.
13- Lee K, Kruper L, Dieli-Conwright CM, Mortimer JE. The Impact of Obesity on Breast Cancer Diagnosis and Treatment. Curr Oncol Rep. 2019 May 27;21(5):41.
14- Espinet-Coll E, López-Nava-Breviere G, Nebreda-Durán J, et al. Documento Español de Consenso en Endoscopia Bariátrica. Parte 1. Consideraciones generales. Revista Española de Enfermedades Digestivas. 2018;110(6):386–99. https://dx.doi.org/10.17235/reed.2018.4503/2016
15- Eduardo Espinet Coll, Gontrand López-Nava Breviere, et al. Documento Español de Consenso en Endoscopia Bariátrica. Parte 2. Tratamientos endoscópicos específicos. Rev Esp Enferm Dig 2019:111(2):140-154. DOI:10.17235/reed.2019.4922/2017
16-Escalada J. Drug approach to treatment for obesity in adults: perspectives and considerations. Rev Esp Enferm Dig. 2024 Jul; 116(7):353-355.